Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01329614 · ClinicalTrials.gov registry record · Early Phase 1
Effects of Nicotine Replacement and Repeated Cue Exposure on Cigarette Craving
A Early Phase 1 study, sponsored by Columbia University.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 40
- Enrollment target
NCT01329614 is a Early Phase 1 study that has completed, run by Columbia University. The registered enrollment target is 40 participants.
The verdict
NCT01329614, a Early Phase 1 study, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 40 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether Cue Extinction Training will reduce relapse rates in cigarette smokers using the patch to quit.
Interventions
- BEHAVIORAL Progressive Muscle Relaxation
- DRUG Nicotine Replacement Therapy
- BEHAVIORAL Cue Extinction Training
- BEHAVIORAL Cue Extinction Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2009-10 |
| Est. Completion | 2013-07 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01329614
The ClinicalTrials.gov registry entry for NCT01329614 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Progressive Muscle Relaxation is the first listed.
NCT01329614 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01329614 about?
NCT01329614 is a clinical study titled "Effects of Nicotine Replacement and Repeated Cue Exposure on Cigarette Craving". The purpose of this study is to determine whether Cue Extinction Training will reduce relapse rates in cigarette smokers using the patch to quit.
What is the current status of trial NCT01329614?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 40 participants. The study started on 2009-10. Estimated completion is 2013-07.
What interventions are being tested in trial NCT01329614?
The interventions under investigation include: Progressive Muscle Relaxation (BEHAVIORAL), Nicotine Replacement Therapy (DRUG), Cue Extinction Training (BEHAVIORAL), Cue Extinction Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT01329614?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.